Horse Sarcoid: Managing a Common Skin Tumor

Sarcoids are the most common skin tumor in horses. While not immediately life-threatening, they can cause significant welfare problems and require careful management decisions.

Key Facts

Sarcoids are locally invasive fibroblastic skin tumors linked to bovine papillomavirus (BPV) infection
They affect approximately 2-7% of horses globally and are the most common equine skin tumor
Six types are recognized: flat (occult), verrucous (warty), nodular, fibroblastic, mixed, and malignant
Fibroblastic sarcoids are aggressive, ulcerate, and cause significant discomfort
Treatment options include topical chemotherapy (cisplatin), immunotherapy, laser, cryotherapy, and surgery
Biopsy without treatment is contraindicated — trauma triggers aggressive regrowth

Welfare Considerations

Sarcoid welfare impacts vary greatly by type and location. Flat and nodular sarcoids may cause minimal discomfort; fibroblastic sarcoids on high-movement areas (eyelids, mouth, pasterns, girth area) cause significant pain, functional impairment, and distress. Periocular sarcoids threatening vision cause chronic ocular irritation. Treatment selection should balance efficacy, recurrence risk, and procedural welfare. Referral to specialist equine oncology centers is appropriate for aggressive sarcoids — undertreated fibroblastic lesions cause progressive, escalating welfare harm.

What You Can Do

Have any new skin lesion on your horse assessed by a vet promptly — early sarcoid treatment is more effective
Never biopsy a sarcoid without concurrent treatment — trauma triggers aggressive regrowth
Seek specialist referral for periocular, fibroblastic, or treatment-resistant sarcoids
Manage sarcoids in high-friction areas (girth, pastern) proactively to prevent ulceration and secondary infection